Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation

Journal of Clinical Investigation

Volumn 123, Issue 9, 2013, Pages 3914-3924

  Takeshita, Sunao ^a   Fumoto, Toshio ^a   Matsuoka, Kazuhiko ^a   Park, Kyoung Ae ^a   Aburatani, Hiroyuki ^b   Kato, Shigeaki ^c   Ito, Masako ^d   Ikeda, Kyoji ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; COLLAGEN TRIPLE HELIX REPEAT CONTAINING 1; HYDROXYAPATITE; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN; UNCLASSIFIED DRUG; CALCIUM; CTHRC1 PROTEIN, MOUSE; SCLEROPROTEIN;

AGING; ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; BONE MASS; BONE REMODELING; BONE TURNOVER; CONTROLLED STUDY; COUPLING FACTOR; DENTIN; EXTRACELLULAR CALCIUM; GENE EXPRESSION; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPENIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; 129 MOUSE; 3T3 CELL LINE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; SECRETION (PROCESS);

3T3-L1 CELLS; ANIMALS; BONE RESORPTION; CALCIUM; CELL DIFFERENTIATION; CELLS, CULTURED; DURAPATITE; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION REGULATION; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOCLASTS; OSTEOGENESIS;

EID: 84883527430     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI69493     Document Type: Article

References (37)

1. Zaidi M. Skeletal remodeling in health and disease. Nat Med. 2007;13(7):791-801. (Pubitemid 47038187)
2. Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell. 2002;2(4):389-406. (Pubitemid 34436569)
3. Hattner R, Epker BN, Frost HM. Suggested sequential mode of control of changes in cell behaviour in adult bone remodelling. Nature. 1965;206(983):489-490.
4. Black DM, et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med. 2003;349:1207-1215. (Pubitemid 37152030)
5. Martin TJ, Sims NA. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med. 2005;11(2):76-81. (Pubitemid 40193486)
6. Tang Y, et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med. 2009;15(7):757-765.
7. Zhao C, et al. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab. 2006;4(2):111-121. (Pubitemid 44138718)
8. Ryu J, Kim HJ, Chang EJ, Huang H, Banno Y, Kim HH. Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. EMBO J. 2006;25(24):5840-5851. (Pubitemid 44967767)
9. Pederson L, Ruan M, Westendorf JJ, Khosla S, Oursler MJ. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci U S A. 2008;105(52):20764-20769.
10. Lotinun S, et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J Clin Invest. 2013;123(2):666-681.
11. Pyagay P, et al. Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration. Circ Res. 2005;96(2):261-268. (Pubitemid 40209374)
12. LeClair R, Lindner V. The role of collagen triple helix repeat containing 1 in injured arteries, collagen expression, and transforming growth factor beta signaling. Trends Cardiovasc Med. 2007;17(6):202-205. (Pubitemid 47089010)
13. Durmus T, LeClair RJ, Park KS, Terzic A, Yoon JK, Lindner V. Expression analysis of the novel gene collagen triple helix repeat containing-1 (Cthrc1). Gene Expr Patterns. 2006;6(8):935-940. (Pubitemid 44309445)
14. Kimura H, et al. Cthrc1 is a positive regulator of osteoblastic bone formation. PLoS One. 2008;3(9):e3174.
15. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26:439-451. (Pubitemid 40686653)
16. Yamamoto S, et al. Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex. Dev Cell. 2008;15(1):23-36. (Pubitemid 351895602)
17. Nakamura T, et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell. 2007;130(5):811-823. (Pubitemid 47332572)
18. Matsumura H, Hasuwa H, Inoue N, Ikawa M, Okabe M. Lineage-specific cell disruption in living mice by Cre-mediated expression of diphtheria toxin A chain. Biochem Biophys Res Commun. 2004;321(2):275-279. (Pubitemid 39055742)
19. Tomimori Y, et al. Evaluation of pharmaceuticals with a novel 50-hour animal model of bone loss. J Bone Miner Res. 2009;24(7):1194-1205.
20. Rodda SJ, McMahon AP. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development. 2006;133(16):3231-3244. (Pubitemid 44404346)
21. Wu X, et al. Inhibition of Sca-1-positive skeletal stem cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone remodeling. Cell Stem Cell. 2010;7(5):571-580.
22. Khosla S. Odanacatib: location and timing are everything. J Bone Miner Res. 2012;27(3):506-508.
23. Pennypacker B, et al. Bone density, strength, and formation in adult cathepsin K (-/-) mice. Bone. 2009;44(2):199-207.
24. Henriksen K, Bollerslev J, Everts V, Karsdal MA. Osteoclast activity and subtypes as a function of physiology and pathology - implications for future treatments of osteoporosis. Endocr Rev. 2011;32(1):31-63.
25. Takahashi H, Epker B, Frost HM. Resorption precedes formative activity. Surg Forum. 1964;15:437-438.
26. Howard GA, Bottemiller BL, Turner RT, Rader JI, Baylink DJ. Parathyroid hormone stimulates bone formation and resorption in organ culture: evidence for a coupling mechanism. Proc Natl Acad Sci U S A. 1981;78(5):3204-3208. (Pubitemid 11032017)
27. Karsdal MA, et al. Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption. Am J Pathol. 2005;166(2):467-476. (Pubitemid 40189043)
28. Lee SH, et al. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med. 2006;12(12):1403-1409.
29. Ishii M, et al. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature. 2009;458(7237):524-528.
30. Takeshita S, et al. SHIP-deficient mice are severely osteoporotic due to increased numbers of hyperresorptive osteoclasts. Nat Med. 2002;8(9):943-949. (Pubitemid 35033697)
31. Takeshita S, Kaji K, Kudo A. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J Bone Miner Res. 2000;15(8):1477-1488. (Pubitemid 30484517)
32. Ishii KA, et al. Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat Med. 2009;15(3):259-266.
33. Tatsumi S, et al. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab. 2007;5(6):464-475. (Pubitemid 46825494)
34. Mundy G, et al. Stimulation of bone formation in vitro and in rodents by statins. Science. 1999;286(5446):1946-1949. (Pubitemid 129515901)
35. Ito M, et al. Multi-detector row CT imaging of vertebral microstructure for evaluation of fracture risk. J Bone Miner Res. 2005;20(10):1828-1836. (Pubitemid 41361884)
36. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R. Guidelines for assessment of bone microstructure in rodents using microcomputed tomography. J Bone Miner Res. 2010;25(7):1468-1486.
37. Dempster DW, et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 2013;28(1):2-17.